Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...
Scientists might be able to quickly predict how ovarian cancer patients are likely to respond to chemotherapy treatment using a simple blood test, according to a Cancer Research UK-funded study ...
Is the Galleri multi-cancer blood test worth it? A doctor's analyses of real-world performance data. Learn why no major medical society recommends the test for screening.
A new tool could be used to help GPs identify patients who may be at higher risk of ovarian cancer. Ovatools combines a blood test which measures levels of cancer antigen 125 (CA125) – a protein often ...
If you've heard of a blood test to detect ovarian cancer, you may want to learn more before asking for the test, called CA 125. There's another test that's more accurate, says Dr. Lovera Wolf Miller, ...
Test demonstrates 89% sensitivity for detection of preclinical stage I/II high grade serous ovarian cancer at 98% specificity in average risk postmenopausal women WALTHAM, Mass., Oct. 28, 2025 ...
Sept. 12 -- FRIDAY, Sept. 11 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new test for women with pelvic tumors that are known to need surgery. The test, called OVA1, will ...
Ovarian cancer spreads fast by recruiting the body’s own protective cells to clear the way—and that secret alliance may finally be its undoing.
A new type of blood test that checks for signs of cancer in healthy people has hit the market. But it's still unclear whether these screening tests will make any difference in cancer death rates. Such ...
Everyday Health on MSN
Ovarian cancer myths vs. facts
Separate facts and misconceptions about ovarian cancer to help better prevent and manage the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results